Biden Administration To Move Forward On Controversial Drug Patent Proposal

Bloomberg Law (6/14, Decker, Lopez, Subscription Publication) reports, “The Biden administration is forging ahead with a divisive, Trump-era regulatory proposal that would limit the government’s ability to control prices on drugs developed from federally...